Gerresheimer (ETR:GXI) received a €72.00 ($88.89) target price from equities researchers at Credit Suisse Group in a report issued on Monday. The firm presently has a “buy” rating on the stock. Credit Suisse Group’s price target would suggest a potential upside of 7.54% from the company’s previous close.
A number of other equities analysts have also recently issued reports on the stock. Hauck & Aufhaeuser set a €52.50 ($64.81) target price on shares of Gerresheimer and gave the stock a “sell” rating in a research report on Friday, April 13th. Deutsche Bank restated a “neutral” rating on shares of Gerresheimer in a research report on Friday, April 13th. Independent Research set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the stock a “neutral” rating in a research report on Thursday, April 12th. Commerzbank set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the stock a “neutral” rating in a research report on Thursday, April 12th. Finally, Berenberg Bank set a €78.00 ($96.30) target price on shares of Gerresheimer and gave the stock a “buy” rating in a research report on Thursday, April 12th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of €67.96 ($83.90).
Shares of GXI opened at €66.95 ($82.65) on Monday. Gerresheimer has a 12-month low of €59.97 ($74.04) and a 12-month high of €78.25 ($96.60).
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.